EP1079017A2 - Strumpf mit einer nahtfrei angebrachten rutschhemmenden Beschichtung im Randbereich der oberen Öffnung - Google Patents
Strumpf mit einer nahtfrei angebrachten rutschhemmenden Beschichtung im Randbereich der oberen Öffnung Download PDFInfo
- Publication number
- EP1079017A2 EP1079017A2 EP00116998A EP00116998A EP1079017A2 EP 1079017 A2 EP1079017 A2 EP 1079017A2 EP 00116998 A EP00116998 A EP 00116998A EP 00116998 A EP00116998 A EP 00116998A EP 1079017 A2 EP1079017 A2 EP 1079017A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- stocking
- coating
- educt
- slip
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000576 coating method Methods 0.000 title claims abstract description 53
- 239000011248 coating agent Substances 0.000 title claims abstract description 49
- 238000007906 compression Methods 0.000 claims abstract description 14
- 230000006835 compression Effects 0.000 claims abstract description 14
- 238000005452 bending Methods 0.000 claims abstract description 10
- 239000000853 adhesive Substances 0.000 claims abstract description 4
- 230000001070 adhesive effect Effects 0.000 claims abstract description 4
- -1 polytetramethylene Polymers 0.000 claims description 46
- 150000002009 diols Chemical class 0.000 claims description 34
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 claims description 16
- 229920000570 polyether Polymers 0.000 claims description 15
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 13
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 10
- 239000007858 starting material Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 claims description 7
- 238000005187 foaming Methods 0.000 claims description 5
- 230000007062 hydrolysis Effects 0.000 claims description 5
- 238000006460 hydrolysis reaction Methods 0.000 claims description 5
- AVWRKZWQTYIKIY-UHFFFAOYSA-N urea-1-carboxylic acid Chemical group NC(=O)NC(O)=O AVWRKZWQTYIKIY-UHFFFAOYSA-N 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 125000000524 functional group Chemical group 0.000 claims description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 230000001588 bifunctional effect Effects 0.000 claims description 3
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 claims description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 21
- 239000000126 substance Substances 0.000 description 16
- 239000000463 material Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 10
- 239000003570 air Substances 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 150000003077 polyols Chemical class 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000007650 screen-printing Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 4
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 4
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 4
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 4
- YNNUSGIPVFPVBX-NHCUHLMSSA-N clemastine Chemical compound CN1CCC[C@@H]1CCO[C@@](C)(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 YNNUSGIPVFPVBX-NHCUHLMSSA-N 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000012948 isocyanate Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 4
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 3
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 3
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 3
- HJJPJSXJAXAIPN-UHFFFAOYSA-N arecoline Chemical compound COC(=O)C1=CCCN(C)C1 HJJPJSXJAXAIPN-UHFFFAOYSA-N 0.000 description 3
- 239000012876 carrier material Substances 0.000 description 3
- 238000005266 casting Methods 0.000 description 3
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- OKJPEAGHQZHRQV-UHFFFAOYSA-N iodoform Chemical compound IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 3
- 150000002513 isocyanates Chemical class 0.000 description 3
- ULSIYEODSMZIPX-UHFFFAOYSA-N phenylethanolamine Chemical compound NCC(O)C1=CC=CC=C1 ULSIYEODSMZIPX-UHFFFAOYSA-N 0.000 description 3
- 229950006768 phenylethanolamine Drugs 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000005496 tempering Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229920001169 thermoplastic Polymers 0.000 description 3
- 239000004416 thermosoftening plastic Substances 0.000 description 3
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 2
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 2
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- JWDYCNIAQWPBHD-UHFFFAOYSA-N 1-(2-methylphenyl)glycerol Chemical compound CC1=CC=CC=C1OCC(O)CO JWDYCNIAQWPBHD-UHFFFAOYSA-N 0.000 description 2
- KVHHQGIIZCJATJ-UHFFFAOYSA-N 1-(4-chlorophenyl)-4-(dimethylamino)-2,3-dimethyl-2-butanol Chemical compound CN(C)CC(C)C(C)(O)CC1=CC=C(Cl)C=C1 KVHHQGIIZCJATJ-UHFFFAOYSA-N 0.000 description 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 2
- IVQOFBKHQCTVQV-UHFFFAOYSA-N 2-hydroxy-2,2-diphenylacetic acid 2-(diethylamino)ethyl ester Chemical compound C=1C=CC=CC=1C(O)(C(=O)OCCN(CC)CC)C1=CC=CC=C1 IVQOFBKHQCTVQV-UHFFFAOYSA-N 0.000 description 2
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 2
- IKQUUYYDRTYXAP-UHFFFAOYSA-N 3-methylpenta-1,4-diene Chemical compound C=CC(C)C=C IKQUUYYDRTYXAP-UHFFFAOYSA-N 0.000 description 2
- PFEOZHBOMNWTJB-UHFFFAOYSA-N 3-methylpentane Chemical compound CCC(C)CC PFEOZHBOMNWTJB-UHFFFAOYSA-N 0.000 description 2
- NFZZDOYBSGWASD-UHFFFAOYSA-N 4-amino-n-pyrimidin-2-ylbenzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1.COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 NFZZDOYBSGWASD-UHFFFAOYSA-N 0.000 description 2
- KFZXVMNBUMVKLN-UHFFFAOYSA-N 4-chloro-5-methyl-2-propan-2-ylphenol Chemical compound CC(C)C1=CC(Cl)=C(C)C=C1O KFZXVMNBUMVKLN-UHFFFAOYSA-N 0.000 description 2
- WFJIVOKAWHGMBH-UHFFFAOYSA-N 4-hexylbenzene-1,3-diol Chemical compound CCCCCCC1=CC=C(O)C=C1O WFJIVOKAWHGMBH-UHFFFAOYSA-N 0.000 description 2
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 2
- QQRSPHJOOXUALR-UHFFFAOYSA-N Apiole Chemical compound COC1=CC(CC=C)=C(OC)C2=C1OCO2 QQRSPHJOOXUALR-UHFFFAOYSA-N 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- GXGJIOMUZAGVEH-UHFFFAOYSA-N Chamazulene Chemical compound CCC1=CC=C(C)C2=CC=C(C)C2=C1 GXGJIOMUZAGVEH-UHFFFAOYSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- OGDVEMNWJVYAJL-LEPYJNQMSA-N Ethyl morphine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OCC OGDVEMNWJVYAJL-LEPYJNQMSA-N 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 2
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 2
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 2
- AJXPJJZHWIXJCJ-UHFFFAOYSA-N Methsuximide Chemical compound O=C1N(C)C(=O)CC1(C)C1=CC=CC=C1 AJXPJJZHWIXJCJ-UHFFFAOYSA-N 0.000 description 2
- FMCGSUUBYTWNDP-UHFFFAOYSA-N Methylephedrine Chemical compound CN(C)C(C)C(O)C1=CC=CC=C1 FMCGSUUBYTWNDP-UHFFFAOYSA-N 0.000 description 2
- SIDLZWOQUZRBRU-UHFFFAOYSA-N Methyprylon Chemical compound CCC1(CC)C(=O)NCC(C)C1=O SIDLZWOQUZRBRU-UHFFFAOYSA-N 0.000 description 2
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 2
- CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- WLWFNJKHKGIJNW-UHFFFAOYSA-N Phensuximide Chemical compound O=C1N(C)C(=O)CC1C1=CC=CC=C1 WLWFNJKHKGIJNW-UHFFFAOYSA-N 0.000 description 2
- AUVVAXYIELKVAI-UHFFFAOYSA-N SJ000285215 Natural products N1CCC2=CC(OC)=C(OC)C=C2C1CC1CC2C3=CC(OC)=C(OC)C=C3CCN2CC1CC AUVVAXYIELKVAI-UHFFFAOYSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- KLBQZWRITKRQQV-UHFFFAOYSA-N Thioridazine Chemical compound C12=CC(SC)=CC=C2SC2=CC=CC=C2N1CCC1CCCCN1C KLBQZWRITKRQQV-UHFFFAOYSA-N 0.000 description 2
- 239000005844 Thymol Substances 0.000 description 2
- ZZHLYYDVIOPZBE-UHFFFAOYSA-N Trimeprazine Chemical compound C1=CC=C2N(CC(CN(C)C)C)C3=CC=CC=C3SC2=C1 ZZHLYYDVIOPZBE-UHFFFAOYSA-N 0.000 description 2
- NIJJYAXOARWZEE-UHFFFAOYSA-N Valproic acid Chemical compound CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 229960003216 aceclidine Drugs 0.000 description 2
- WRJPSSPFHGNBMG-UHFFFAOYSA-N acetic acid 1-azabicyclo[2.2.2]octan-3-yl ester Chemical compound C1CC2C(OC(=O)C)CN1CC2 WRJPSSPFHGNBMG-UHFFFAOYSA-N 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 2
- SLRCCWJSBJZJBV-UHFFFAOYSA-N alpha-isosparteine Natural products C1N2CCCCC2C2CN3CCCCC3C1C2 SLRCCWJSBJZJBV-UHFFFAOYSA-N 0.000 description 2
- NFHVTCJKAHYEQN-UHFFFAOYSA-N amfetaminil Chemical compound C=1C=CC=CC=1C(C#N)NC(C)CC1=CC=CC=C1 NFHVTCJKAHYEQN-UHFFFAOYSA-N 0.000 description 2
- 229950000762 amfetaminil Drugs 0.000 description 2
- 229960001498 benactyzine Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229940036350 bisabolol Drugs 0.000 description 2
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 2
- 229960002504 capsaicin Drugs 0.000 description 2
- 235000017663 capsaicin Nutrition 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 2
- 229960004926 chlorobutanol Drugs 0.000 description 2
- 229960003993 chlorphenesin Drugs 0.000 description 2
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 2
- 229960005233 cineole Drugs 0.000 description 2
- 229960002735 clobutinol Drugs 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- HFXKQSZZZPGLKQ-UHFFFAOYSA-N cyclopentamine Chemical compound CNC(C)CC1CCCC1 HFXKQSZZZPGLKQ-UHFFFAOYSA-N 0.000 description 2
- 229960003263 cyclopentamine Drugs 0.000 description 2
- 229960004397 cyclophosphamide Drugs 0.000 description 2
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- AUVVAXYIELKVAI-CKBKHPSWSA-N emetine Chemical compound N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC AUVVAXYIELKVAI-CKBKHPSWSA-N 0.000 description 2
- 229960002694 emetine Drugs 0.000 description 2
- SLWGJZPKHAXZQL-UHFFFAOYSA-N emylcamate Chemical compound CCC(C)(CC)OC(N)=O SLWGJZPKHAXZQL-UHFFFAOYSA-N 0.000 description 2
- AXJXURWWUFZZKN-UHFFFAOYSA-N enallylpropymal Chemical compound C=CCC1(C(C)C)C(=O)NC(=O)N(C)C1=O AXJXURWWUFZZKN-UHFFFAOYSA-N 0.000 description 2
- 229950009181 enallylpropymal Drugs 0.000 description 2
- 229960002179 ephedrine Drugs 0.000 description 2
- QFXZANXYUCUTQH-UHFFFAOYSA-N ethynol Chemical compound OC#C QFXZANXYUCUTQH-UHFFFAOYSA-N 0.000 description 2
- 229960002428 fentanyl Drugs 0.000 description 2
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 2
- IRYFCWPNDIUQOW-UHFFFAOYSA-N fluanisone Chemical compound COC1=CC=CC=C1N1CCN(CCCC(=O)C=2C=CC(F)=CC=2)CC1 IRYFCWPNDIUQOW-UHFFFAOYSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- BCQZXOMGPXTTIC-UHFFFAOYSA-N halothane Chemical compound FC(F)(F)C(Cl)Br BCQZXOMGPXTTIC-UHFFFAOYSA-N 0.000 description 2
- 239000012943 hotmelt Substances 0.000 description 2
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 2
- 229960001680 ibuprofen Drugs 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- WFLSCFISQHLEED-UHFFFAOYSA-N isoaminile Chemical compound CN(C)C(C)CC(C(C)C)(C#N)C1=CC=CC=C1 WFLSCFISQHLEED-UHFFFAOYSA-N 0.000 description 2
- 229960004216 isoaminile Drugs 0.000 description 2
- 229960001614 levamisole Drugs 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 229960003861 mephenesin Drugs 0.000 description 2
- 229960003729 mesuximide Drugs 0.000 description 2
- RFKMCNOHBTXSMU-UHFFFAOYSA-N methoxyflurane Chemical compound COC(F)(F)C(Cl)Cl RFKMCNOHBTXSMU-UHFFFAOYSA-N 0.000 description 2
- 229960002455 methoxyflurane Drugs 0.000 description 2
- QXLPXWSKPNOQLE-UHFFFAOYSA-N methylpentynol Chemical compound CCC(C)(O)C#C QXLPXWSKPNOQLE-UHFFFAOYSA-N 0.000 description 2
- 229960000316 methyprylon Drugs 0.000 description 2
- MJFJKKXQDNNUJF-UHFFFAOYSA-N metixene Chemical compound C1N(C)CCCC1CC1C2=CC=CC=C2SC2=CC=CC=C21 MJFJKKXQDNNUJF-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 2
- WEYVCQFUGFRXOM-UHFFFAOYSA-N perazine Chemical compound C1CN(C)CCN1CCCN1C2=CC=CC=C2SC2=CC=CC=C21 WEYVCQFUGFRXOM-UHFFFAOYSA-N 0.000 description 2
- 229960000482 pethidine Drugs 0.000 description 2
- 229960004227 phensuximide Drugs 0.000 description 2
- FWWDFDMCZLOXQI-UHFFFAOYSA-N pivhydrazine Chemical compound CC(C)(C)C(=O)NNCC1=CC=CC=C1 FWWDFDMCZLOXQI-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 2
- 229960004919 procaine Drugs 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000005060 rubber Substances 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- SLRCCWJSBJZJBV-AJNGGQMLSA-N sparteine Chemical compound C1N2CCCC[C@H]2[C@@H]2CN3CCCC[C@H]3[C@H]1C2 SLRCCWJSBJZJBV-AJNGGQMLSA-N 0.000 description 2
- 229960001945 sparteine Drugs 0.000 description 2
- 229960002784 thioridazine Drugs 0.000 description 2
- 229960000790 thymol Drugs 0.000 description 2
- 229960004605 timolol Drugs 0.000 description 2
- 229960001722 verapamil Drugs 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- 235000005282 vitamin D3 Nutrition 0.000 description 2
- 239000011647 vitamin D3 Substances 0.000 description 2
- 229940021056 vitamin d3 Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- SLRCCWJSBJZJBV-LXTVHRRPSA-N (-)-Spartein Natural products C1N2CCCC[C@@H]2[C@H]2CN3CCCC[C@@H]3[C@H]1C2 SLRCCWJSBJZJBV-LXTVHRRPSA-N 0.000 description 1
- FMCGSUUBYTWNDP-ONGXEEELSA-N (1R,2S)-2-(dimethylamino)-1-phenyl-1-propanol Chemical compound CN(C)[C@@H](C)[C@H](O)C1=CC=CC=C1 FMCGSUUBYTWNDP-ONGXEEELSA-N 0.000 description 1
- CEMAWMOMDPGJMB-CYBMUJFWSA-N (2r)-1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol Chemical compound CC(C)NC[C@@H](O)COC1=CC=CC=C1OCC=C CEMAWMOMDPGJMB-CYBMUJFWSA-N 0.000 description 1
- GRWFGVWFFZKLTI-YGPZHTELSA-N (5r)-4,6,6-trimethylbicyclo[3.1.1]hept-3-ene Chemical compound C1C2CC=C(C)[C@]1([H])C2(C)C GRWFGVWFFZKLTI-YGPZHTELSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- RKUNBYITZUJHSG-FXUDXRNXSA-N (S)-atropine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 RKUNBYITZUJHSG-FXUDXRNXSA-N 0.000 description 1
- ZWLMLVIUWRUDBD-BTJKTKAUSA-N (z)-but-2-enedioate;3-(2-methoxy-10h-phenothiazin-10-ium-10-yl)propyl-dimethylazanium Chemical compound OC(=O)\C=C/C(O)=O.C1=CC=C2N(CCCN(C)C)C3=CC(OC)=CC=C3SC2=C1 ZWLMLVIUWRUDBD-BTJKTKAUSA-N 0.000 description 1
- 239000001074 1-methoxy-4-[(E)-prop-1-enyl]benzene Substances 0.000 description 1
- KWTSXDURSIMDCE-UHFFFAOYSA-N 1-phenylpropan-2-amine Chemical compound CC(N)CC1=CC=CC=C1 KWTSXDURSIMDCE-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- XILVEPYQJIOVNB-UHFFFAOYSA-N 2-[3-(trifluoromethyl)anilino]benzoic acid 2-(2-hydroxyethoxy)ethyl ester Chemical compound OCCOCCOC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 XILVEPYQJIOVNB-UHFFFAOYSA-N 0.000 description 1
- UDKVBVICMUEIKS-UHFFFAOYSA-N 4-[(6-chloro-2-methoxyacridin-9-yl)azaniumyl]pentyl-diethylazanium;dichloride Chemical compound Cl.Cl.C1=C(OC)C=C2C(NC(C)CCCN(CC)CC)=C(C=CC(Cl)=C3)C3=NC2=C1 UDKVBVICMUEIKS-UHFFFAOYSA-N 0.000 description 1
- QKICWELGRMTQCR-UHFFFAOYSA-N 4-[(7-chloroquinolin-4-yl)azaniumyl]pentyl-diethylazanium;dihydrogen phosphate Chemical compound OP(O)(O)=O.OP(O)(O)=O.ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 QKICWELGRMTQCR-UHFFFAOYSA-N 0.000 description 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- WNCAVNGLACHSRZ-KAMYIIQDSA-N Allithiamine Chemical compound C=CCSSC(/CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-KAMYIIQDSA-N 0.000 description 1
- WNCAVNGLACHSRZ-UHFFFAOYSA-N Allithiamine Natural products C=CCSSC(CCO)=C(C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-UHFFFAOYSA-N 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 229930008564 C01BA04 - Sparteine Natural products 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- DBZHHRPNWDNKNX-UHFFFAOYSA-N Chamazulen Natural products CC1=CC=C2C=C(C=CC(=C12)C(C)C)C DBZHHRPNWDNKNX-UHFFFAOYSA-N 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- MBYXEBXZARTUSS-QLWBXOBMSA-N Emetamine Natural products O(C)c1c(OC)cc2c(c(C[C@@H]3[C@H](CC)CN4[C@H](c5c(cc(OC)c(OC)c5)CC4)C3)ncc2)c1 MBYXEBXZARTUSS-QLWBXOBMSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- OGDVEMNWJVYAJL-UHFFFAOYSA-N Ethylmorphine Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OCC OGDVEMNWJVYAJL-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- ISFHAYSTHMVOJR-UHFFFAOYSA-N Phenindamine Chemical compound C1N(C)CCC(C2=CC=CC=C22)=C1C2C1=CC=CC=C1 ISFHAYSTHMVOJR-UHFFFAOYSA-N 0.000 description 1
- QZVCTJOXCFMACW-UHFFFAOYSA-N Phenoxybenzamine Chemical compound C=1C=CC=CC=1CN(CCCl)C(C)COC1=CC=CC=C1 QZVCTJOXCFMACW-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 1
- IFFPICMESYHZPQ-UHFFFAOYSA-N Prenylamine Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)CCNC(C)CC1=CC=CC=C1 IFFPICMESYHZPQ-UHFFFAOYSA-N 0.000 description 1
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- MOYKHGMNXAOIAT-OMMKOOBNSA-N [(3s,3as,6s,6ar)-3-nitrooxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@H]2[C@@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-OMMKOOBNSA-N 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- BLAKAEFIFWAFGH-UHFFFAOYSA-N acetyl acetate;pyridine Chemical compound C1=CC=NC=C1.CC(=O)OC(C)=O BLAKAEFIFWAFGH-UHFFFAOYSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 230000001171 adenosinetriphosphoric effect Effects 0.000 description 1
- 229960003790 alimemazine Drugs 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229960002213 alprenolol Drugs 0.000 description 1
- PAZJSJFMUHDSTF-UHFFFAOYSA-N alprenolol Chemical compound CC(C)NCC(O)COC1=CC=CC=C1CC=C PAZJSJFMUHDSTF-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 229960003116 amyl nitrite Drugs 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
- 229960000830 captopril Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- DLNKOYKMWOXYQA-IONNQARKSA-N cathine Chemical compound C[C@H](N)[C@@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-IONNQARKSA-N 0.000 description 1
- 229960003609 cathine Drugs 0.000 description 1
- PMRJYBALQVLLSJ-UHFFFAOYSA-N chamazulene Natural products CCC1=CC2=C(C)CCC2=CC=C1 PMRJYBALQVLLSJ-UHFFFAOYSA-N 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 239000007805 chemical reaction reactant Substances 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 1
- 229960004630 chlorambucil Drugs 0.000 description 1
- 229940031956 chlorothymol Drugs 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- PUFQVTATUTYEAL-UHFFFAOYSA-N cinchocaine Chemical compound C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCCN(CC)CC)=C21 PUFQVTATUTYEAL-UHFFFAOYSA-N 0.000 description 1
- 229960001747 cinchocaine Drugs 0.000 description 1
- 229960002881 clemastine Drugs 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- SOYKEARSMXGVTM-HNNXBMFYSA-N dexchlorpheniramine Chemical compound C1([C@H](CCN(C)C)C=2N=CC=CC=2)=CC=C(Cl)C=C1 SOYKEARSMXGVTM-HNNXBMFYSA-N 0.000 description 1
- 229960001882 dexchlorpheniramine Drugs 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- OWQIUQKMMPDHQQ-UHFFFAOYSA-N dimethocaine Chemical compound CCN(CC)CC(C)(C)COC(=O)C1=CC=C(N)C=C1 OWQIUQKMMPDHQQ-UHFFFAOYSA-N 0.000 description 1
- 229950010160 dimethocaine Drugs 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- MSYUMPGNGDNTIQ-UHFFFAOYSA-N dixyrazine Chemical compound C12=CC=CC=C2SC2=CC=CC=C2N1CC(C)CN1CCN(CCOCCO)CC1 MSYUMPGNGDNTIQ-UHFFFAOYSA-N 0.000 description 1
- 229960005146 dixyrazine Drugs 0.000 description 1
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- AUVVAXYIELKVAI-UWBTVBNJSA-N emetine Natural products N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@H]1CC AUVVAXYIELKVAI-UWBTVBNJSA-N 0.000 description 1
- JPGQOUSTVILISH-UHFFFAOYSA-N enflurane Chemical compound FC(F)OC(F)(F)C(F)Cl JPGQOUSTVILISH-UHFFFAOYSA-N 0.000 description 1
- 229960000305 enflurane Drugs 0.000 description 1
- HAPOVYFOVVWLRS-UHFFFAOYSA-N ethosuximide Chemical compound CCC1(C)CC(=O)NC1=O HAPOVYFOVVWLRS-UHFFFAOYSA-N 0.000 description 1
- 229960002767 ethosuximide Drugs 0.000 description 1
- 229960004578 ethylmorphine Drugs 0.000 description 1
- 229960001493 etofenamate Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229950010338 fencarbamide Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007646 gravure printing Methods 0.000 description 1
- 229960003132 halothane Drugs 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 229960003258 hexylresorcinol Drugs 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229930005342 hyoscyamine Natural products 0.000 description 1
- 229960003210 hyoscyamine Drugs 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 description 1
- MOYKHGMNXAOIAT-JGWLITMVSA-N isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 description 1
- 229960000201 isosorbide dinitrate Drugs 0.000 description 1
- 229940116298 l- malic acid Drugs 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960001797 methadone Drugs 0.000 description 1
- 229950008620 methopromazine Drugs 0.000 description 1
- 229960002221 methylephedrine Drugs 0.000 description 1
- 229960001344 methylphenidate Drugs 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- CSDTZUBPSYWZDX-UHFFFAOYSA-N n-pentyl nitrite Chemical compound CCCCCON=O CSDTZUBPSYWZDX-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- NCYVXEGFNDZQCU-UHFFFAOYSA-N nikethamide Chemical compound CCN(CC)C(=O)C1=CC=CN=C1 NCYVXEGFNDZQCU-UHFFFAOYSA-N 0.000 description 1
- 229960003226 nikethamide Drugs 0.000 description 1
- 229910052756 noble gas Inorganic materials 0.000 description 1
- 150000002835 noble gases Chemical class 0.000 description 1
- MOYZEMOPQDTDHA-UHFFFAOYSA-N norscopolamine Natural products C1C(C2OC22)NC2CC1OC(=O)C(CO)C1=CC=CC=C1 MOYZEMOPQDTDHA-UHFFFAOYSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229960005152 pentetrazol Drugs 0.000 description 1
- 229960002195 perazine Drugs 0.000 description 1
- 229960003534 phenindamine Drugs 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 229960003418 phenoxybenzamine Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229960001416 pilocarpine Drugs 0.000 description 1
- 229950008099 pivhydrazine Drugs 0.000 description 1
- 229920006149 polyester-amide block copolymer Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229960001989 prenylamine Drugs 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- CDOZDBSBBXSXLB-UHFFFAOYSA-N profenamine Chemical compound C1=CC=C2N(CC(C)N(CC)CC)C3=CC=CC=C3SC2=C1 CDOZDBSBBXSXLB-UHFFFAOYSA-N 0.000 description 1
- 229960002262 profenamine Drugs 0.000 description 1
- OJCPSBCUMRIPFL-UHFFFAOYSA-N prolintane Chemical compound C1CCCN1C(CCC)CC1=CC=CC=C1 OJCPSBCUMRIPFL-UHFFFAOYSA-N 0.000 description 1
- 229960004654 prolintane Drugs 0.000 description 1
- 229960003910 promethazine Drugs 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- BZGIPVGCJGXQTA-UHFFFAOYSA-N s-[2-(diethylamino)ethyl] n,n-diphenylcarbamothioate Chemical compound C=1C=CC=CC=1N(C(=O)SCCN(CC)CC)C1=CC=CC=C1 BZGIPVGCJGXQTA-UHFFFAOYSA-N 0.000 description 1
- 150000003902 salicylic acid esters Chemical class 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000012748 slip agent Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229920006132 styrene block copolymer Polymers 0.000 description 1
- 150000003440 styrenes Chemical class 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- ZEWQUBUPAILYHI-UHFFFAOYSA-N trifluoperazine Chemical compound C1CN(C)CCN1CCCN1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 ZEWQUBUPAILYHI-UHFFFAOYSA-N 0.000 description 1
- 229960002324 trifluoperazine Drugs 0.000 description 1
- IRYJRGCIQBGHIV-UHFFFAOYSA-N trimethadione Chemical compound CN1C(=O)OC(C)(C)C1=O IRYJRGCIQBGHIV-UHFFFAOYSA-N 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 229940048102 triphosphoric acid Drugs 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 229960000604 valproic acid Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Images
Classifications
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06N—WALL, FLOOR, OR LIKE COVERING MATERIALS, e.g. LINOLEUM, OILCLOTH, ARTIFICIAL LEATHER, ROOFING FELT, CONSISTING OF A FIBROUS WEB COATED WITH A LAYER OF MACROMOLECULAR MATERIAL; FLEXIBLE SHEET MATERIAL NOT OTHERWISE PROVIDED FOR
- D06N3/00—Artificial leather, oilcloth or other material obtained by covering fibrous webs with macromolecular material, e.g. resins, rubber or derivatives thereof
- D06N3/12—Artificial leather, oilcloth or other material obtained by covering fibrous webs with macromolecular material, e.g. resins, rubber or derivatives thereof with macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. gelatine proteins
- D06N3/14—Artificial leather, oilcloth or other material obtained by covering fibrous webs with macromolecular material, e.g. resins, rubber or derivatives thereof with macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. gelatine proteins with polyurethanes
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41B—SHIRTS; UNDERWEAR; BABY LINEN; HANDKERCHIEFS
- A41B11/00—Hosiery; Panti-hose
- A41B11/02—Reinforcements
- A41B11/04—Reinforcements of the stocking top
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41B—SHIRTS; UNDERWEAR; BABY LINEN; HANDKERCHIEFS
- A41B11/00—Hosiery; Panti-hose
- A41B11/12—Means at the upper end to keep the stockings up
- A41B11/126—Means at the upper end to keep the stockings up having friction increasing means
- A41B11/128—Means at the upper end to keep the stockings up having friction increasing means in discontinuous form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/06—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings
- A61F13/08—Elastic stockings; for contracting aneurisms
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/65—Low-molecular-weight compounds having active hydrogen with high-molecular-weight compounds having active hydrogen
- C08G18/66—Compounds of groups C08G18/42, C08G18/48, or C08G18/52
- C08G18/6603—Compounds of groups C08G18/42, C08G18/48, or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38
- C08G18/6607—Compounds of groups C08G18/42, C08G18/48, or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38 with compounds of group C08G18/3203
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04B—KNITTING
- D04B1/00—Weft knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes
- D04B1/22—Weft knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes specially adapted for knitting goods of particular configuration
- D04B1/24—Weft knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes specially adapted for knitting goods of particular configuration wearing apparel
- D04B1/26—Weft knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes specially adapted for knitting goods of particular configuration wearing apparel stockings
- D04B1/265—Surgical stockings
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06N—WALL, FLOOR, OR LIKE COVERING MATERIALS, e.g. LINOLEUM, OILCLOTH, ARTIFICIAL LEATHER, ROOFING FELT, CONSISTING OF A FIBROUS WEB COATED WITH A LAYER OF MACROMOLECULAR MATERIAL; FLEXIBLE SHEET MATERIAL NOT OTHERWISE PROVIDED FOR
- D06N7/00—Flexible sheet materials not otherwise provided for, e.g. textile threads, filaments, yarns or tow, glued on macromolecular material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
- Y10T428/24777—Edge feature
- Y10T428/24785—Edge feature including layer embodying mechanically interengaged strands, strand portions or strand-like strips [e.g., weave, knit, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
- Y10T428/24802—Discontinuous or differential coating, impregnation or bond [e.g., artwork, printing, retouched photograph, etc.]
- Y10T428/2481—Discontinuous or differential coating, impregnation or bond [e.g., artwork, printing, retouched photograph, etc.] including layer of mechanically interengaged strands, strand-portions or strand-like strips
- Y10T428/24818—Knitted, with particular or differential bond sites or intersections
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
- Y10T442/20—Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
- Y10T442/2344—Coating or impregnation is anti-slip or friction-increasing other than specified as an abrasive
Definitions
- the invention relates to a stocking with a seamlessly attached slip-resistant or anti-slip coating in the edge area of the upper opening of the Stocking, especially an anti-thrombosis stocking.
- Anti-slip or preventive equipment for such stockings are also known.
- anti-slip coatings for the sole area or the edge area at the stocking opening are also known.
- these coatings are based on natural and synthetic Polymers.
- amide, silicone, acrylate, vinyl and styrene compounds but also the use of rubber and latex are known.
- US 3,983,870 discloses a non-slip support for limbs, in particular a medical stocking.
- the anti-slip coating come among others Acrylates and rubbers are used.
- Urethanes are mentioned, but not disclosed are crosslinked oligomeric diols. A sewn-on adhesive edge is described in the disclosure.
- FR 2 609 889 describes a special pattern for an anti-slip tape. A description there is no seamless application of an anti-slip tape.
- WO 97/45081 discloses a stocking for medical purposes with a special one Polyurethane thread for generating compression. There is also a stripe on the ankle area appropriate. However, the seamless application of the strip is not shown.
- the object of the invention is to create a stocking with an anti-slip coating to provide, which is suitable for medical requirements and which the does not have disadvantages known from the prior art.
- the invention relates to a stocking with a seamlessly attached anti-slip or anti-slip coating in the edge area of the upper Opening the stocking with the edge of the stocking stretching from 10% to 350% produces a compression pressure of 3 to 45 mm Hg and the edge one width-related bending stiffness (DIN 53121) of at least 20 cN x mm. Furthermore, the adhesive force of the coating is in the area of the stocking opening the stocking at least 3 N / cm.
- the coating preferably contains a polyadduct with a phase 1 and a phase 2, the mass fraction of phase 1 being greater than 60% by weight.
- Phase 1 is a polyaddition product composed of at least one educt E1 and at least one educt E3, educt E1 being an oligomeric diol which has a hydroxyl number of more than 20 mg KOH / g (diol), and educt E3 being a silicone-free, at least bifunctional Reaction reactant with a molecular weight of less than 300 g / mol.
- Phase 2 is a polyaddition product composed of at least one educt E2 and at least one educt E3, the educt E2 having at least partially terminal functional groups.
- the coating has a molar ratio of the educts E3 to be crosslinked to the sum of one or more oligomeric diols (educt E1) and the proportion of further educts E2 having a quotient of 0.9 to 1.1.
- the hydroxyl number describes a measure that indicates how many milligrams of potassium hydroxide are equivalent to the amount of acetic acid that is bound by 1 g of substance during acetylation.
- the sample is generally boiled with acetic anhydride pyridine and the resulting acid is titrated with KOH solution.
- the hydroxyl number which is used to assess reactive resins, waxes, fats, oils, solvents, etc., is related, in Anglo-American studies it is identical to the acetyl number. Further information can be found in the DIN standards 53 240 (12/1971) and 53 240-2 (12/1993).
- the ratio of the mass fraction of phase 1 and phase 2 is greater than 1.5. In further advantageous versions between 1.8 and 100, particularly advantageously 2.0 to 20.
- the mass fraction of phase 1 is more preferably between 67% by weight and 98% by weight. Polyadducts with a weight fraction of 75% by weight to 98% by weight in phase 1 are particularly advantageous, 76% by weight to 95% by weight being particularly suitable.
- a modified functional anti-slip coating is due to the Foaming the same achieved.
- the anti-slip substances to be used are preferably inert Gases such as nitrogen, carbon dioxide, noble gases, hydrocarbons or air or their mixtures foamed. In some cases, foaming has been added through thermal decomposition of gas-developing substances such as azo, carbonate and Hydrazide compounds have been found to be suitable.
- the degree of foaming ie the gas content
- the advantageous properties of the foamed coating are the good conformability even on uneven surfaces due to the elasticity and plasticity of the foamed device.
- thermoplastic anti-slip mass under high pressure at a temperature above the softening point (about 180 ° C) with the gases provided, such as nitrogen, air or carbon dioxide, in different volume fractions (about 10% by volume to 80% by volume) implemented a stator / rotor system. While the gas admission pressure is greater than 100 bar, the mixed pressures gas / thermoplastic in the system are 40 to 100 bar, preferably 40 to 70 bar.
- the anti-slip foam thus produced can then reach the application plant via a line.
- Commercially available nozzle, extruder or chamber systems are used for the application.
- the areas of the stocking coated with the anti-slip finish are permeable to water vapor and air.
- the amount of anti-slip agent required is significantly reduced without impairing the properties.
- the mass is partially on the edge area of the stocking is applied, for example by screen printing, thermal screen printing, thermoflexo printing or gravure printing, because substrates coated in full lines can cause mechanical skin irritation during application.
- the anti-slip equipment can, for example, also be sprayed on or be spun, which results in a more or less irregular order picture.
- the partial application enables the transepidermal to be removed through regulated channels Water loss and improves the evaporation of the skin when sweating in particular when using air and water vapor permeable stockings. This will cause skin irritation caused by congestion of body fluids are avoided.
- the created drainage channels enable one Derive.
- the application is preferred in the form of polygeometric domes and very particularly of domes in which the diameter to height ratio is less than 5: 1.
- other shapes and patterns can also be printed on the stocking material, for example a printed image in the form of alphanumeric character combinations or patterns such as grids, strips and zigzag lines.
- the anti-slip substance can be evenly distributed on the stocking material, but it can also be applied to the product in different thicknesses or densely to suit the function of the product.
- thermal screen printing is to use a rotating one heated, seamless, drum-shaped perforated round stencil that goes over a nozzle is loaded with the preferred mass.
- a specially shaped nozzle lip (round or Square knife) presses the mass fed through a channel through the perforation the stencil wall onto the carrier web that passes by. This is with a Speed that corresponds to the speed of rotation of the rotating sieve drum, by means of a counter pressure roller against the outer jacket of the heated sieve drum guided.
- the web / hole ratio can be less than 10: 1 be, preferably less than or equal to 1: 1, in particular equal to 1:10.
- the described mechanism of formation of the domes preferably requires absorbent or at least stocking materials wettable by the cohesive mass.
- Difficult to wet stocking surfaces have to be chemical or physical Procedure to be pretreated. This can be done through additional measures such as for example corona discharge or coating with wetting improving Substances happen.
- the size and shape of the domes can be defined.
- the base diameter of the calottes can be chosen from 10 ⁇ m to 10000 ⁇ m, the height of the calottes from 20 ⁇ m to 2000 ⁇ m, preferably 50 ⁇ m to 1000 ⁇ m, with the small diameter range for smooth stockings, the larger diameter and larger calotte height for rough ones or highly porous stocking materials is provided.
- the positioning of the calottes on the stocking is defined by the geometry of the application, which can be varied within wide limits, for example engraving or sieve geometry. With the help of the parameters shown, the desired property profile of the coating can be set very precisely, adjusted to the different carrier materials and applications.
- the stocking material is preferably at a speed of greater than 2 m / min, preferably 20 to 220 m / min, coated, the coating temperature being greater than the softening temperature is to be selected.
- the anti-slip or anti-slip mass can have a basis weight of greater than 3 g / m 2 , preferably between 6 g / m 2 and 1000 g / m 2 , very particularly preferably between 9 g / m 2 and 750 g / m 2 , on the stocking material be applied.
- basis weights 300 to 700 g / m 2 are necessary.
- small cutouts are used for the stocking edge with a high width-related bending stiffness (DIN 53121).
- the percentage of the surface partially coated with the mass should be at least 5% and can range up to approximately 95% for special products preferably 20% to 60% and 70% to 95%. This can be done if necessary Multiple application or special deformation steps can be achieved, where appropriate masses with different properties can also be used. For special hosiery applications, 10 to 50% of the coating area is equipped.
- Fabrics on a thermoplastic basis serve as anti-slip equipment are characterized by good washability, skin tolerance and thermal stability.
- the substances used have a shrinkage of less than 10% after at least five washes, at least at a washing temperature in the range from 5 to 96 ° C or at temperatures around and above 100 ° C.
- the anti-slip coating should therefore be particularly resistant to hydrolysis in the temperature range from 5 ° C to 100 ° C.
- the use of at least partially linear polymers based on crosslinked oligomeric diols (E1) is advantageous for a supple, anti-slip or anti-slip finish, because uncrosslinked oligomeric diols are little or not wash-resistant. In addition, an anti-slip or anti-slip effect cannot be determined with uncrosslinked diols.
- the oligomeric diol to be used is generally a synthesis product which is converted into an anti-slip material by polyaddition.
- oligomeric diols with a hydroxyl number (DIN 53240) of at least 20 are necessary, preferably 40 to 230 mg KOH / g, particularly preferably 65 to 224 mg KOH / g, very particularly preferably 70 to 150 mg KOH / g.
- DIN 53240 hydroxyl number
- Polyethers, special polyesters, polyacrylic and methacrylic acid compounds can be used. Polyethers based on polyethylene oxide diol, polypropylene oxide diol and polytetramethylene oxide diol are generally advantageous.
- Representatives of the second educt group (E2) are low molecular weight diols or diamines. This includes ethanediol, butanediol and hexanediol, but also various aliphatic diamines. Terminal binding of the hydroxyl or amino group in each case is also advantageous.
- the educt E2 is preferably a 1,2-ethanediol, 1,4-butanediol, 1,6-hexanediol and / or a mixture of the aforementioned.
- Representatives of the third educt group (E3) also have, at least in part, terminal ones functional groups.
- the use of is particularly preferred for crosslinking one or more silicone-free bifunctional reactants with a molecular weight of less than 300 g / mol in the starting form.
- Most important representative of this Group are compounds containing epoxy and isocyanate.
- the educt is preferably E3 an aliphatic or aromatic diisocyanate.
- the coating contains less than 5% by weight of allophanate groups, preferably 0.01 to 2% by weight.
- the anti-slip coating if the coating in the Temperature range from 5 ° C to 100 ° C is resistant to hydrolysis.
- the anti-slip coating can be initiated, catalytic or substances with a stabilizing effect are added.
- the coating can also contain active ingredients are added, preferably in quantitative concentrations of or Active ingredients between 0.01 to 50 wt .-%, preferably 0.1 to 20 wt .-%.
- the distribution of the active ingredients in the coating can be done in a thermal homogenizer such as thermomixers, thermo kneaders, roller mills or screw systems be performed.
- the addition of the active ingredient can be made in the fully prepared Coating take place, this can just as well in an intermediate stage or in the starting mixture be incorporated.
- the stocking materials can have at least one meshed elastic thread and / or have at least one woven elastic thread.
- Such stocking materials are used for the production of stockings, which in generally consist of a spatially limited tubular knitted fabric.
- Circular knitted or knitted tubular goods made of elastic are advantageous Material, especially fibers or threads.
- Starting materials serve as the basis on a natural and synthetic basis, such as polyester, polyester amide, urethane, olefins, acrylates, vinyl compounds and block copolymers, such as styrene block copolymers, as well as native or regenerated cellulose.
- the stocking equipped with the anti-slip coating should in particular at an elongation of 10% to 350% a compression pressure of 8 to 25 mm Hg build up.
- the stocking should have a pressure gradient that drops from distal to proximal.
- the relative drop in compression pressure should not exceed 80%, preferably 30% to 70%.
- the stocking is preferably less than a length 130 cm. Stockings with a length of 30 to 110 cm are particularly preferred preferably from 35 to 95 cm.
- the scope of the product in the expanded state is up to 95 cm, preferably less than 90 cm, particularly preferably from 16 to 87 cm.
- Width-related bending stiffnesses achieved of at least are advantageous 40 cN x mm, preferably 80 to 350 cN x mm, particularly preferably 100 to 180 cN x mm.
- the coating is used on an essentially anatomically shaped compression stocking, formed from at least one knitted elastic thread, the anti-slip or anti-slip coating being applied in the upper opening area of the stocking.
- the compression stocking can develop a compression force of 15 to 25 mm Hg in the lower stocking area and a compression force of 8 to 15 mm Hg in the upper stocking area, a width-related bending stiffness (DIN 53121) from 40 cN x mm to 180 cN x mm and one from proximal to have a distally decreasing pressure curve.
- the anti-slip finish here consists of 95 to 99.8% by weight of a polyadduct based on a polytetramethylene oxide diol, 1.4 butanediol and 4,4'-diphenylmethane diisocyanate, the weight fraction formed from polytetramethylene oxide diol and 4,4'-diphenylmethane diisocyanate greater than 78% by weight .-% and the molar ratio of 4.4 -Diphenylmethane diisocyanate to the sum of polytetramethylene oxide diol and 1.4 butanediol is between and 0.96 and 1.01.
- the coating of the anti-slip or anti-slip equipment can in direct procedures and transfer procedures. That is advantageous Application from the melt, in this case there is no need to remove auxiliaries, such as in the coating from solutions or dispersions is the case.
- the polyadducts in the One-shot process ".
- the preparation of isocyanate-crosslinked oligomeric diols is particularly advantageous. Aliphatic and aromatic isocyanates with two or three terminal functional groups can be used.
- the oligomeric polyol (E1) used was melted in a forced air oven and brought to a starting temperature of 84 ° C. After this temperature had been reached, the starting material (E2) and the starting material (E3), which had also been melted and heated to 50 ° C., were added. Mixing was continued at about 120 ° C until the casting temperature was reached. The reaction mixture was then poured into a Teflon-coated tub and kept on a hot table at 120 ° C. until the 10th minute after the start of the reaction. The mixing temperature depends on the hard segment proportion. The tempering was carried out at 85 ° C for 16 hours in a forced air oven. After grinding, the granules obtained were again tempered at 110 ° C. for 5 hours. To shorten the tempering process, the polyadduct can also be prepared and granulated in an extruder.
- the proportion of allophanate groups should be a maximum of 5% by weight. Allophanate group fractions of less than 2 are preferred % By weight, a proportion of less than 0.5% by weight is particularly preferred.
- the share of reactive groups of the educt E3 should complete after the completion of the crosslinking less than 0.5%, preferably less than 0.3%.
- the water content in the oligomeric diol (E1) and in the starting material (E2) was less than 0.3%.
- the hydroxyl number of the oligomeric polyols is described in the table below. Diol Polyether 1 Polyether 2 Polyether 3 Polyether 4 Polyester 1 Hydroxyl number 112.9 73 46.3 112 115
- the anti-slip substance for the equipment according to the invention it is necessary to use the anti-slip substance to coat on the stocking material. This can be done directly or by transfer respectively.
- the coating can be carried out with or without interruption. In principle, there can be coating-free spots or only partial coating spots getting produced. This is about the usual coating processes such as spray, print, especially raster, engraving and screen printing possible. Another Punching, milling or cutting a full-surface coating is possible with the subsequent transfer of the anti-slip or hindering substance.
- An anatomically shaped stocking with a compression pressure of 12 mm Hg at the top opening was made by stitching nylon threads.
- the coating in the opening area was carried out at a temperature of 165 ° C.
- Eight strips of 6 mm x 30 mm were coated in a V-shape.
- the mass application was converted to one square meter and was 500 g / m 2 .
- a cross-linked oligomeric diol based on polyether was used as an anti-slip substance used.
- 1,4-butanediol and 4 ', 4-diphenylmethane diisocyanate were further educts used.
- the hydroxyl number of the oligomeric diol was 73 mg KOH / g.
- the water content The 1,4-butanediol and the oligomeric diol were made according to Karl Fischer certainly. The water content was less than 0.2%.
- the oligomeric polyol (E1) used was melted in a forced air oven and brought to a starting temperature of 84 ° C. After this temperature had been reached, the starting material (E2) and the starting material (E3), which had also been melted and heated to 50 ° C., were added. Mixing was continued at about 120 ° C until the casting temperature was reached. The reaction mixture was then poured into a Teflon-coated tub and kept on a hot table at 120 ° C. until the 10th minute after the start of the reaction. The mixing temperature depends on the proportion of phase 1. The tempering was carried out at 85 ° C for 16 hours in a forced air oven. After grinding, the granules obtained were again tempered at 110 ° C. for 5 hours. Weight raw materials D Polyether 1 Polyether 2 134.61 Polyether 3 MDI 53.85 1.4 butanediol 11.54 Reference mass 200
- the rest of the isocyanate content was less than 0.1%.
- the share of the first phase had a weight fraction of 78% by weight and the molar ratio of E 3 to E1 + E2 was 0.998.
- the applied anti-slip polyadduct is very cuddly. After ten Washes at 95 ° C showed an almost unchanged anti-slip effect. The coating did not become detached or dissolved after the wash cycles detected. The anti-slip finish is silicone-free and not sticky. The bending stiffness was 45 cN x mm.
Landscapes
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dispersion Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Polyurethanes Or Polyureas (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Socks And Pantyhose (AREA)
Abstract
Description
Dies ist nicht nur unvorteilhaft hinsichtlich der Kosten, sondern auch für das Handling in der Fertigung. Vorteilhaft ist jedoch die Flexibilität in der Produktgestaltung sowie die Festigkeit des Verbundes. Weiter bildet dieser Rand, welcher in der Regel aus einem anderen Material besteht, einen Schutz gegen das Umschlagen der Kante.
Phase 1 ist ein Polyadditionsprodukt aus mindestens einem Edukt E1 und mindestens einem Edukt E3 ist, wobei Edukt E1 ein oligomeres Diol darstellt, welches eine Hydroxylzahl von mehr als 20 mg KOH/g (Diol) aufweist, und wobei Edukt E3 ein silikonfreies, zumindest bifunktionelles Reaktionsedukt mit einem Molekulargewicht von weniger als 300 g/mol ist.
Die Beschichtung weist ein Stoffmengenverhältnis der zu vernetzenden Edukte E3 zu der Summe aus einem oder mehreren oligomeren Diolen (Edukt E1) und dem Anteil weiterer Edukte E2 einen Quotienten von 0,9 bis 1,1 auf.
Die Hydroxylzahl, die zur Beurteilung von Reaktionsharzen, Wachsen, Fetten, Ölen, Lösungsmitteln usw. dient, ist verwandt, in angloamerikanischen Untersuchungen identisch mit der Acetylzahl.
Weiterführende Angaben lassen sich in den DIN-Normen 53 240 (12/1971) und 53 240-2 (12/1993) finden.
Weiter vorzugsweise ist der Masseanteil von Phase 1 zwischen 67 Gew. -% und 98 Gew.-%. Besonders vorteilhaft sind Polyaddukte mit Gewichtsanteil von 75 Gew.-% bis 98 Gew.-% in der Phase 1, besonders geeignet 76 Gew.-% bis 95 Gew.-%.
Die vorteilhaften Eigenschaften der geschäumten Beschichtung sind die gute Anschmiegsamkeit auch an unebenen Flächen durch die Elastizität und Plastizität der geschäumten Vorrichtung.
Während der Gasvordruck größer 100 bar ist, betragen die Mischdrucke Gas/Thermoplast im System 40 bis 100 bar, bevorzugt 40 bis 70 bar. Der so hergestellte Antirutschschaum kann anschließend über eine Leitung in das Auftragswerk gelangen. Bei dem Auftragswerk finden handelsübliche Düsen-, Extruder- oder Kammersysteme Verwendung.
Durch die Schäumung der Beschichtung und die dadurch entstandenen offenen Poren in der Masse sind bei Verwendung eines an sich porösen Strumpfmaterials die mit der rutschhemmenden Ausrüstung beschichteten Bereiche des Strumpfes gut wasserdampf- und luftdurchlässig. Die benötigte Antirutschmittelmenge wird erheblich reduziert ohne Beeinträchtigung und Wirkungsweise der Eigenschaften.
Die rutschhemmende Substanz kann gleichmäßig auf dem Strumpfmaterial verteilt sein, sie kann aber auch funktionsgerecht für das Produkt über die Fläche unterschiedlich stark oder dicht aufgetragen sein.
Die Positionierung der Kalotten auf dem Strumpf wird durch die in weiten Grenzen variierbare Geometrie des Auftragswerkes, zum Beispiel Gravur- oder Siebgeometrie, definiert festgelegt. Mit Hilfe der aufgezeigten Parameter kann über einstellbare Größen das gewünschte Eigenschaftsprofil der Beschichtung, abgestimmt auf die verschiedenen Trägermaterialien und Anwendungen, sehr genau eingestellt werden.
Die rutschhemmende Beschichtung sollte also ganz besonders im Temperaturbereich von 5 °C bis 100 °C hydrolysebeständig sein.
Das einzusetzende oligomere Diol ist in der Regel ein Syntheseprodukt, welches durch Polyaddition zu einem rutschhemmenden Material umgesetzt wird. Für die spezielle Verwendung als rutschhemmende oder -hindernde Substanz sind oligomere Diole mit einer Hydroxylzahl (DIN 53240) von mindestens 20 notwendig, bevorzugt 40 bis 230 mg KOH/g, besonders bevorzugt 65 bis 224 mg KOH/g, ganz besonders bevorzugt 70 bis 150 mg KOH/g. Bei der Auswahl der Diole ist auf die ausreichende Hydrolysebeständigkeit zu achten. Polyether, spezielle Polyester, Polyacryl- und Methacrylsäureverbindungen sind verwendbar. Generell sind Polyether auf Basis von Polyethylenoxiddiol, Polypropylenoxiddiol und Polytetramethylenoxiddiol vorteilhaft.
Vorzugsweise ist das Edukt E2 ein 1,2-Ethandiol, 1,4 Butandiol, 1,6 Hexandiol und/oder eine Mischung aus den vorgenannten.
Typische verabreichbare Stoffe sind hierbei:
Die rutschhemmende Ausrüstung besteht hier zu 95 bis 99,8 Gew.-% aus einem Polyaddukt auf Basis eines Polytetramethylenoxiddiol, 1,4 Butandiol und 4,'4 Diphenylmethandiisocyanat, wobei der Gewichtsanteil gebildet aus Polytetramethylenoxiddiol und 4,4'-Diphenylmethandiisocyanat größer 78 Gew.-% ist und das Stoffmengenverhältnis von 4,4-Diphenylmethandiisocyanat zu der Summe aus Polytetramethylenoxiddiol und 1,4 Butandiol zwischen und 0,96 und 1,01 beträgt.
- Figur 1
- zeigt einen Auftrag mit V-Form,
- Figur 2
- zeigt einen Auftrag in X-Form,
- Figur 3
- zeigt einen Auftrag in Linienform,
- Figur 4
- zeigt ebenfalls einen Auftrag in Linienform, wobei die Linien eine Neigung aufweisen und dichter gesetzt sind als in Figur 3, und
- Figur 5
- stellt eine Kombination des Auftrages in
2"- und S-Form dar.
Zur Verkürzung des Tempervorganges kann das Polyaddukt auch in einem Extruder aufbereitet und granuliert werden.
| Einwaage | |||||
| Rohstoffe | A | B | C | D | E |
| Polyether 1 | 129,32 | 128,57 | |||
| Polyether 2 | 134,61 | ||||
| Polyether 3 | 162,72 | 144,47 | |||
| MDI | 60,09 | 60,84 | 31,63 | 53,85 | 45,03 |
| 1,4 Butandiol | 10,59 | 10,59 | 5,64 | 11,54 | 10,50 |
| Bezugsmasse | 200 | 200 | 200 | 200 | 200 |
| Einwaage | |||
| Rohstoffe | F | G | H |
| Polyether 4 | 135,9 | ||
| Polyester 1 | 129 | 143,61 | |
| MDI | 54,24 | 60,5 | 51,06 |
| 1,4Butandiol | 10,5 | 5,32 | |
| 1,6 Hexandiol | 9,86 | ||
| Bezugsmasse | 200 | 200 | 200 |
| Diol | |||||
| Polyether 1 | Polyether 2 | Polyether 3 | Polyether 4 | Polyester 1 | |
| Hydroxylzahl | 112,9 | 73 | 46,3 | 112 | 115 |
| Einwaage | |
| Rohstoffe | D |
| Polyether 1 | |
| Polyether 2 | 134,61 |
| Polyether 3 | |
| MDI | 53,85 |
| 1,4 Butandiol | 11,54 |
| Bezugsmasse | 200 |
Claims (16)
- Strumpf mit einer nahtfrei angebrachten rutschhemmenden Beschichtung im Randbereich der oberen Öffnung des Strumpfes, wobeider Rand des Strumpfes bei einer Dehnung von 10 % bis 350 % einen Kompressionsdruck von 3 bis 45 mm Hg erzeugt sowie der Rand eine breitenbezogene Biegesteifigkeit (DIN 53121) von mindestens 20 cN x mm aufweistund im Bereich der Strumpföffnung die Haftkraft der Beschichtung auf dem Strumpf mindestens 3 N/cm beträgt.
- Strumpf nach Anspruch 1, dadurch gekennzeichnet, daß die Beschichtung beinhaltet ein Polyaddukt mit einer Phase 1 und einer Phase 2, wobei der Masseanteil von Phase 1 größer 60 Gew.-% ist,Phase 1 ein Polyadditionsprodukt aus mindestens einem Edukt E1 und mindestens einem Edukt E3 ist, wobei Edukt E1 ein oligomeres Diol darstellt, welches eine Hydroxylzahl von mehr als 20 mg KOH/g (Diol) aufweist, und wobei Edukt E3 ein silikonfreies, zumindest bifunktionelles Reaktionsedukt mit einem Molekulargewicht von weniger als 300 g/mol ist,Phase 2 ein Polyadditionsprodukt aus mindestens einem Edukt E2 und mindestens einem Edukt E3 ist, wobei das Edukt E2 wenigstens teilweise endständige funktionelle Gruppen aufweist unddie Beschichtung ein Stoffmengenverhältnis der zu vernetzenden Edukte E3 zu der Summe aus einem oder mehreren oligomeren Diolen (Edukt 1) und dem Anteil weiterer Edukte E2 einen Quotienten von 0,9 bis 1,1 aufweist.
- Strumpf nach den Ansprüchen 1 und 2, dadurch gekennzeichnet, daß der Strumpf zumindest einen vermaschten elastischen Faden und/oder zumindest einen verwebten elastischen Faden beinhaltet.
- Strumpf nach den Ansprüchen 1 bis 3, dadurch gekennzeichnet, daß die Beschichtung im Temperaturbereich von 5 °C bis 100 °C hydrolysebeständig ist.
- Strumpf nach mindestens einem vorangegangenen Anspruch, dadurch gekennzeichnet, daß die Beschichtung einen Schäumungsgrad von zumindest 5 Vol.-%, insbesondere 5 bis 85 Vol.-%, bevorzugt 10 bis 75 Vol.-%, besonders bevorzugt 20 bis 60 Vol.-% beträgt.
- Strumpf nach mindestens einem vorangegangenen Anspruch, dadurch gekennzeichnet, daß die Beschichtung weniger als 5 Gew.-%, bevorzugt 0,01 bis 2 Gew.-% Allophanatgruppen beinhaltet.
- Strumpf nach mindestens einem vorangegangenen Anspruch, dadurch gekennzeichnet, daß die Beschichtung auf dem Strumpfrand in Form von Stäbchen, Linien, in V-Form, in S-Form, in Z-Form und/oder deren Kombinationen aufgetragen ist.
- Strumpf nach mindestens einem vorangegangenen Anspruch, dadurch gekennzeichnet, daß das Verhältnis vom Edukt 3 zu der Summe der Edukte 1 und Edukte 2 zwischen 0,91 und 1,05, besonders bevorzugt 0,92 bis 1,02 liegt.
- Strumpf nach mindestens einem vorangegangenen Anspruch, dadurch gekennzeichnet, daß der Gewichtsanteil der Phase 1 wenigstens 72 %' bevorzugt 75 bis 98 % besonders bevorzugt 76 bis 95 % beträgt.
- Strumpf nach mindestens einem vorangegangenen Anspruch, dadurch gekennzeichnet, daß das oligomere Diol ein Polyetherdiol, insbesondere ein Polytetramethylenoxiddiol oder Polyethylenoxiddiol oder deren Mischungen ist, eine Hydroxylzahl von 40 bis 230 mg KOH/g, bevorzugt 65 bis 224 mg KOH/g, besonders bevorzugt 70 bis 150 mg KOH/g, aufweist.
- Strumpf nach mindestens einem vorangegangenen Anspruch, dadurch gekennzeichnet, daß das Edukt E2 ein 1,2-Ethandiol, 1,4 Butandiol, 1,6 Hexandiol und/oder eine Mischung aus den vorgenannten ist.
- Strumpf nach mindestens einem vorangegangenen Anspruch, dadurch gekennzeichnet, daß das Edukt E3 ein aliphatisches oder aromatisches Diisocyanat ist.
- Strumpf nach mindestens einem vorangegangenen Anspruch, dadurch gekennzeichnet, daß der Strumpf bei einer Dehnung von 10% bis 350% einen Kompressionsdruck von 8 bis 25 mm Hg aufbaut.
- Strumpf nach mindestens einem vorangegangenen Anspruch, dadurch gekennzeichnet, daß der Strumpf einen von distal nach proximal abfallenden Druckverlauf aufweist.
- Strumpf nach mindestens einem vorangegangenen Anspruch, dadurch gekennzeichnet, daß der Rand des Strumpfes eine breitenbezogene Biegesteifigkeit (DIN 53121) von mindestens 40 cN x mm aufweist, bevorzugt zwischen 80 und 350 cN x mm, ganz besonders bevorzugt 100 bis 180 cN x mm.
- Strumpf nach mindestens einem vorangegangenen Anspruch, gebildet aus mindestens einem gemaschten elastischen Faden, mit einer rutschhemmenden oder rutschverhindernden Beschichtung im oberen Öffnungsbereich des Strumpfes, mit einer Kompressionskraft von 15 bis 25 mm Hg im unteren Strumpfbereich und einer Kompressionskraft von 8 bis 15 mm Hg im oberen Strumpfbereich, einer breitenbezogenen Biegesteifigkeit (DIN 53121) von 40 cN x mm bis 180 cN x mm, einen von proximal nach distal abfallenden Druckverlauf aufweist, dadurch gekennzeichnet, daß die rutschhemmende Ausrüstung zu 95 bis 99,8 Gew.-% ein Polyaddukt auf Basis eines Polytetramethylenoxiddiol, 1,4 Butandiol und 4,4-Diphenylmethandiisocyanat besteht, wobei der Gewichtsanteil gebildet aus Polytetramethylenoxiddiol und 4,4'-Diphenylmethandiisocyanat größer 78 Gew.-% ist und das Stoffmengenverhältnis von 4,4
-Diphenylmethandiisocyanat zu der Summe aus Polytetramethylenoxiddiol und 1,4 Butandiol zwischen und 0,96 und 1,01 beträgt.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19940018A DE19940018A1 (de) | 1999-08-24 | 1999-08-24 | Strumpf mit einer nahtfrei angebrachten rutschhemmenden Beschichtung im Randbereich der oberen Öffnung |
| DE19940018 | 1999-08-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1079017A2 true EP1079017A2 (de) | 2001-02-28 |
| EP1079017A3 EP1079017A3 (de) | 2001-10-31 |
Family
ID=7919372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP00116998A Withdrawn EP1079017A3 (de) | 1999-08-24 | 2000-08-08 | Strumpf mit einer nahtfrei angebrachten rutschhemmenden Beschichtung im Randbereich der oberen Öffnung |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US6673421B1 (de) |
| EP (1) | EP1079017A3 (de) |
| AU (1) | AU776616B2 (de) |
| DE (1) | DE19940018A1 (de) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2902608A1 (fr) * | 2006-06-22 | 2007-12-28 | Dbapparel Operations Soc Par A | Article tricote chaussant,notamment mi-bas relaxants |
| FR2930708A1 (fr) * | 2008-04-30 | 2009-11-06 | Ganzoni France Soc Par Actions | Bande auto-fixante de maintien et de contention notamment pour bas de contention |
| WO2016022345A1 (en) * | 2014-08-05 | 2016-02-11 | Bsn Medical , Inc. | Therapeutic medical compression garment and method |
| BE1024974B1 (nl) * | 2017-07-20 | 2018-08-29 | Deco-Vision Bvba | Medische kous |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10148127B4 (de) * | 2001-09-28 | 2004-02-05 | Saric, Krunoslav, Dr. | Kompressionsmanschette zur Behandlung von Extremitäten |
| DE10219814B4 (de) * | 2003-05-31 | 2004-11-25 | Technische Universität Dresden | Physiologische Manschette |
| US6871516B2 (en) | 2002-05-14 | 2005-03-29 | Bsn-Jobst | Anti-slip garment |
| US7908674B2 (en) * | 2004-07-09 | 2011-03-22 | Jones Karen E | Body-shaping apparel |
| US20060260024A1 (en) * | 2005-05-18 | 2006-11-23 | Seung-Hee Lee | Sock having part for preventing slipping-down phenomenon of sock |
| FR2891555B1 (fr) * | 2005-10-03 | 2007-12-21 | Textiles Well Sa | Procede de depot d'un materiau anti-glissement, article vestimentaire et article chaussant obtenus par ce procede |
| US20100325806A1 (en) * | 2007-10-09 | 2010-12-30 | Sealy Technology, Llc | Pressure dispersion support systems |
| US20100100024A1 (en) * | 2008-10-17 | 2010-04-22 | Reid Jr Lawrence G | Anti-slip Mechanism, Garment, and Methods |
| EP2243386A2 (de) * | 2009-04-20 | 2010-10-27 | Sarah Stabile | Socke mit Griff |
| US20180360139A9 (en) * | 2009-06-24 | 2018-12-20 | Nike, Inc. | Aerodynamic Garment With Applied Edge Treatments |
| US10918141B2 (en) | 2009-06-24 | 2021-02-16 | Nike, Inc. | Drag-reducing exercise equipment |
| US20140230124A1 (en) * | 2011-10-11 | 2014-08-21 | Puma SE | Article of clothing |
| DE102012216180B4 (de) | 2012-09-12 | 2026-05-07 | Falke Kgaa | Beinbekleidungsstück |
| FR3008585B1 (fr) | 2013-07-19 | 2015-07-31 | Dbapparel Operations | Article textile de lingerie a maintien ameliore |
| DE102014103309A1 (de) | 2014-03-12 | 2015-09-17 | Falke Kgaa | Verfahren zum Herstellen eines Bekleidungsstücks und Bekleidungsstück |
| DE102014111939A1 (de) * | 2014-08-21 | 2016-02-25 | Ntt New Textile Technologies Gmbh | Verfahren zur Herstellung eines Bekleidungsstücks |
| NL2013644B1 (nl) * | 2014-10-17 | 2016-10-04 | Steps Holding Bv | Kousenvoet alsmede werkwijze voor het vervaardigen van een dergelijke kousenvoet. |
| US10583046B2 (en) | 2015-08-12 | 2020-03-10 | Eric Wilson | Compression garments and uses thereof |
| US10413479B2 (en) * | 2017-02-23 | 2019-09-17 | Carrie Green | Pressure point sleep garment |
| NL2019463B1 (nl) * | 2017-08-30 | 2019-03-11 | Steps Holding Bv | Kousenvoet alsmede werkwijze voor het vervaardigen van een dergelijke kousenvoet |
| EP3549562B1 (de) * | 2018-04-03 | 2020-07-29 | medi GmbH & Co. KG | Haftband für kleidungsstücke, insbesondere für medizinische kompressionsstrümpfe oder bandagen |
| US11006686B2 (en) * | 2018-05-31 | 2021-05-18 | Nike, Inc. | Grip-enhancing film for cuff edges |
| TWM584110U (zh) * | 2018-07-30 | 2019-10-01 | 李根園 | 無束痕襪子 |
| IT202000017821A1 (it) * | 2020-07-23 | 2022-01-23 | Fastmeditalia Srl | Calza compressoria terapeutica e procedimento per la produzione di una calza copressoria terapeutica. |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2514108A (en) * | 1947-08-30 | 1950-07-04 | Henry J Vogt | Self-supporting hosiery |
| NL6715320A (de) * | 1966-11-14 | 1968-05-15 | ||
| US3728875A (en) * | 1971-01-07 | 1973-04-24 | Kendall & Co | Stocking with soft inner thigh area |
| US3983870A (en) * | 1975-04-21 | 1976-10-05 | Minnesota Mining And Manufacturing Company | Slip resistant body limb support and method of preparation |
| US4021860A (en) * | 1976-04-13 | 1977-05-10 | The Kendall Company | Non-slip therapeutic stocking and method |
| DE8814047U1 (de) * | 1988-11-10 | 1988-12-29 | Bauerfeind GmbH & Co, 4152 Kempen | Kompressionsstrumpf |
| DE3902434A1 (de) * | 1989-01-27 | 1990-08-02 | Uhl Sportartikel Karl | Stuetzbandagen fuer gliedmassen und/oder gelenke |
| CH678867A5 (de) * | 1989-04-13 | 1991-11-15 | Ganzoni & Cie Ag St Gallen | |
| JPH0734886Y2 (ja) * | 1991-05-28 | 1995-08-09 | 株式会社ワコール | 被 服 |
| AU8110494A (en) * | 1993-11-04 | 1995-05-23 | Smith & Nephew Plc | Bandages |
| DE19620109A1 (de) * | 1996-05-18 | 1997-11-20 | Beiersdorf Ag | Selbstklebend beschichtetes, luftdurchlässiges Trägermaterial, Verfahren zu dessen Herstellung und Verwendung |
| US5708118A (en) * | 1996-10-11 | 1998-01-13 | Arco Chemical Technology, L.P. | Spandex elastomers |
| DE19824649C2 (de) * | 1998-05-23 | 2001-01-25 | Weihermueller & Voigtmann | Gelenkbandage |
-
1999
- 1999-08-24 DE DE19940018A patent/DE19940018A1/de not_active Withdrawn
-
2000
- 2000-08-08 EP EP00116998A patent/EP1079017A3/de not_active Withdrawn
- 2000-08-16 AU AU53433/00A patent/AU776616B2/en not_active Ceased
- 2000-08-23 US US09/644,302 patent/US6673421B1/en not_active Expired - Lifetime
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2902608A1 (fr) * | 2006-06-22 | 2007-12-28 | Dbapparel Operations Soc Par A | Article tricote chaussant,notamment mi-bas relaxants |
| FR2930708A1 (fr) * | 2008-04-30 | 2009-11-06 | Ganzoni France Soc Par Actions | Bande auto-fixante de maintien et de contention notamment pour bas de contention |
| WO2009138672A3 (fr) * | 2008-04-30 | 2010-02-18 | Ganzoni & Cie Ag | Bande auto-fixante de maintien et de contention notamment pour bas de contention |
| US10194700B2 (en) | 2008-04-30 | 2019-02-05 | Ganzoni & Cie Ag | Self-adhesive posture and splinting band in particular for compression stocking |
| WO2016022345A1 (en) * | 2014-08-05 | 2016-02-11 | Bsn Medical , Inc. | Therapeutic medical compression garment and method |
| US9849039B2 (en) | 2014-08-05 | 2017-12-26 | Bsn Medical, Inc. | Therapeutic medical compression garment and method |
| BE1024974B1 (nl) * | 2017-07-20 | 2018-08-29 | Deco-Vision Bvba | Medische kous |
| EP3430923A1 (de) * | 2017-07-20 | 2019-01-23 | DeCo-Vision BVBA | Medizinische strumpfe |
Also Published As
| Publication number | Publication date |
|---|---|
| DE19940018A1 (de) | 2001-03-01 |
| AU776616B2 (en) | 2004-09-16 |
| AU5343300A (en) | 2001-03-22 |
| EP1079017A3 (de) | 2001-10-31 |
| US6673421B1 (en) | 2004-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1079017A2 (de) | Strumpf mit einer nahtfrei angebrachten rutschhemmenden Beschichtung im Randbereich der oberen Öffnung | |
| DE68901805T2 (de) | Durch waerme versiegelbare membrane fuer die transdermale abgabe von arzneimittelwirkstoffen. | |
| EP0901357B1 (de) | Partiell selbstklebend beschichtetes trägermaterial, verfahren zu dessen herstellung und verwendung | |
| DE69620261T2 (de) | Orthopädischer steifverbandartikel mit harten und weichen bereichen | |
| DE19749467C2 (de) | Wirkstoffhaltige Pflaster | |
| DE68910867T2 (de) | Matrix für die transdermale Abgabe von Arzneimitteln. | |
| WO2018149835A1 (de) | Verfahren zur herstellung eines klebstofffreien wundkontaktverbundmaterials | |
| EP3478738A1 (de) | Klebstoff auf basis eines speziellen polyurethanharnstoffs sowie dessen herstellung und anwendung | |
| EP2846653A1 (de) | Thermisch fixierbares flächengebilde | |
| EP0846463B1 (de) | Wirkstoffhaltige Pflaster | |
| EP1085914B1 (de) | Wirkstoffhaltige pflaster | |
| EP0446431B1 (de) | Trägermaterial für medizinische Zwecke | |
| EP1079016A2 (de) | Rutschhemmende Beschichtung auf den Körper bedeckende Trägermaterialien sowie Verwendung derselben | |
| EP1053030B1 (de) | Trägermaterial für medizinische zwecke | |
| DE60303297T2 (de) | Elastischer vliesstoff | |
| DE2632618C3 (de) | Verfahren zur Herstellung von Kunstleder mit geschäumten Urethanschichten | |
| DE19804604A1 (de) | Vorrichtung zur Freigabe von Stoffen | |
| EP1177266A1 (de) | Trägermaterial mit kohäsiver haftmasse | |
| DE2726569C2 (de) | ||
| DE19962747A1 (de) | Orthopädische Bandage | |
| EP1089775A1 (de) | Orthopädische bandage | |
| DE69320774T2 (de) | Feuchtigkeitsdurchlässiges tuch und verfahren zu seiner herstellung | |
| DE19925058C1 (de) | Orthopädische Bandage | |
| DE19964422B4 (de) | Orthopädische Bandage | |
| DE2218740A1 (de) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
| AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7D 06N 3/12 A, 7D 06N 7/00 B, 7A 41B 11/12 B, 7C 08G 18/66 B, 7A 41B 11/04 B, 7A 61F 13/08 B, 7D 06N 3/14 B |
|
| 17P | Request for examination filed |
Effective date: 20020215 |
|
| AKX | Designation fees paid |
Free format text: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| 17Q | First examination report despatched |
Effective date: 20041021 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20050301 |